NCT05333731 is a clinical trial of Oxytocin in Failed Trial of Labor, Unspecified, With Delivery, sponsored by The First Affiliated Hospital with Nanjing Medical University.

Who is sponsoring NCT05333731?

NCT05333731 is sponsored by The First Affiliated Hospital with Nanjing Medical University.

What drugs are being tested in NCT05333731?

Interventions in NCT05333731: Oxytocin.

What condition does NCT05333731 study?

NCT05333731 studies Failed Trial of Labor, Unspecified, With Delivery, Failed VBAC (Vaginal Birth After Caesarean), Prelabor Rupture of Membranes, Failed Induction (of Labor) by Oxytocin.

Is NCT05333731 still recruiting?

NCT05333731 is currently status unknown. Last updated 19 April 2022.

Last reviewed 2022-04-19 · How we verify

NCT05333731

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oxytocin Induction in Full Term Pregnant Women With Cesarean Section of Prelabor Rupture of Membranes

Status unknown Last updated 19 April 2022

What this trial tests

trial testing Oxytocin in Failed Trial of Labor, Unspecified, With Delivery in 528 participants. Status unknown.

Timeline

30 March 2022

Primary endpoint
30 December 2024

30 June 2025

Quick facts

Lead sponsor	The First Affiliated Hospital with Nanjing Medical University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	528
Start date	30 March 2022
Primary completion	30 December 2024
Estimated completion	30 June 2025
Sites	1 location across China

Drugs / interventions tested

Oxytocin (OXYTOCIN) — full drug profile →

Conditions studied

Failed Trial of Labor, Unspecified, With Delivery — all drugs for Failed Trial of Labor, Unspecified, With Delivery →
Failed VBAC (Vaginal Birth After Caesarean) — all drugs for Failed VBAC (Vaginal Birth After Caesarean) →
Prelabor Rupture of Membranes — all drugs for Prelabor Rupture of Membranes →
Failed Induction (of Labor) by Oxytocin — all drugs for Failed Induction (of Labor) by Oxytocin →

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Who can join

Adults 20 to 40, female only, with Failed Trial of Labor, Unspecified, With Delivery or Failed VBAC (Vaginal Birth After Caesarean). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a multi-center, prospective, observational clinical trial study. 528 full-term pregnant women will be enrolled as subjects, and the ratio of eligible subjects in the two groups is 1:1. In the cesarean section group, full term pregnant women with prelabor rupture of membrane (PROM) who are willing to try the trial of labor after cesarean (TOLAC) and in accordance with the criteria according to the 2016 China vaginal birth after cesarean (VBAC) clinical management guidelines will be enrolled and recorded by our homemade registration form of TOLAC. In the non-cesarean section group, pregnant women after 37 weeks of gestation with PROM but without vaginal labor contraindications will be enrolled. Whether in the cesarean section group or non-cesarean section group, if spontaneous labor does not occur, and they all will be induced by oxytocin. After 24 hours, their final delivery mode will be recorded. In the following 42 days postpartum, their complications and the neonatal outcome will be followed up.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Oxytocin

Trials testing the same drug.

NCT07401524 — Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage · Phase 4 · not yet recruiting
NCT07188207 — Rectal Misoprostol for Reducing Blood Loss in Elective Cesarean Section · NA · not yet recruiting
NCT06968481 — Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage · Phase 2 · not yet recruiting
NCT07265180 — Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison · NA · recruiting
NCT07119398 — Oxytocin/Foley vs. Oxytocin for Induction in Patients With PPROM · Phase 4 · recruiting

Other The First Affiliated Hospital with Nanjing Medical University trials

Trials by the same sponsor.

NCT07377981 — An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyp · Phase 4 · not yet recruiting
NCT07523789 — Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC · not yet recruiting
NCT07464756 — SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer · Phase 2 · not yet recruiting
NCT07482826 — Full-Endoscopic Decompression vs. Endoscopic Lumbar Fusion for Middle-Aged and Older Adults With Spinal Stenosis · NA · not yet recruiting
NCT07558863 — Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05333731 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The First Affiliated Hospital with Nanjing Medical University
Last refreshed: 19 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05333731.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing